1. Homepagina
  2. Aandelen
  3. Verenigd Koninkrijk
  4. London Stock Exchange
  5. Diaceutics PLC
  6. Nieuws
  7. Andere talen
    DXRX   GB00BJQTGV64

DIACEUTICS PLC

(DXRX)
  Rapport
Vertraagde tijd London Stock Exchange  -  25/05 14:07:00 CEST
108.75 GBX   -1.58%
05/05Diaceutics sluit $1 miljoen data-abonnementscontract met farmaceutisch bedrijf
MT
05/05Diaceutics PLC sluit vijfjarig contract voor meerdere producten met een wereldwijd top-30 farmaceutisch bedrijf
CI
23/03Winst Flash (DXRX.L) DIACEUTICS boekt FY21 inkomsten GBP13.9M
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op DIACEUTICS PLC
05/05Diaceutics Bags $1 Million Data Subscription Deal With Pharma Company
05/05Diaceutics PLC Secures Five-Year, Multi-Product Subscription Contract with A Top 30 Glo..
23/03TRANSCRIPT : Diaceutics PLC, 2021 Earnings Call, Mar 23, 2022
23/03Earnings Flash (DXRX.L) DIACEUTICS Posts FY21 EPS GBX0.66
23/03Earnings Flash (DXRX.L) DIACEUTICS Posts FY21 Revenue GBP13.9M
22/03Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2021
18/03Diaceutics' New CFO Assumes Role
18/03Diaceutics Announces Executive Changes
14/02Diaceutics Wins $3 Million Data Subscription Contract with Life Sciences Group
14/02Diaceutics PLC Secures Three Year Data Subscription Contract with A Global Life Science..
11/01Diaceutics Hires Ergomed Official as CFO
11/01Diaceutics plc Announces Chief Financial Officer Change
11/01Diaceutics plc Announces Directorate Change
2021Diaceutics PLC Secures Five Year Subscription Contract with A Top Five Global Life Scie..
2021Diaceutics PLC Announces Test Signal Launch and Contract Wins
2021Diaceutics PLC Announces Unaudited Consolidated Earnings Results for the Six Months End..
2021Diaceutics PLC Provides Earnings Guidance for the Year 2021
2021Diaceutics PLC Secures Contract with A Global Pharmaceutical Company for the Provision ..
2021DIACEUTICS : Announces Two Poster Presentations at AMP 2021 Annual Meeting & Expo
2021DIACEUTICS : Two New Experts Join the Diaceutics Advisory Panel
2021Diaceutics plc Provides Revenue guidance for the Six Months Ended June 30, 2021
2021Diaceutics PLC Wins New Contract
2021TRANSCRIPT : Diaceutics PLC - Analyst/Investor Day
2021DIACEUTICS : to Release Breakthrough Data on COVID-19 Impact on Cancer at 2021 American So..
2021DIACEUTICS : and LGC SeraCare Partnership Expands Diagnostic Commercialization Solutions E..
2021Diaceutics PLC Announces New Partnership with LGC SeraCare
2021DIACEUTICS : Appoints Yvanka Gilliam as Vice President of Operations, Asia Pacific
2021Diaceutics plc Announces COVID-19 Testing Data Licensing Agreement
2021DIACEUTICS : Earnings Flash (DXRX.L) DIACEUTICS Reports FY20 Revenue GBP12.7M
2021Diaceutics PLC Announces Audited Group Earnings Results for the Year Ended 31 December ..
2021Diaceutics PLC Provides Revenue Guidance for the Full Year of Fiscal 2021
2021DIACEUTICS : Appoints Nikita Lynn to Vice President of Finance
2021Diaceutics PLC Appoints Nikita Lynn as Vice President of Finance
2021DIACEUTICS : Canadian Pathology Quality Assurance Leverages Diaceutics' DXRX Platform to A..
2021Diaceutics PLC Provides Revenue Guidance for Year Ended 31 December 2020
2020DIACEUTICS : Appoints Seasoned Business Leader Deborah Davis as Non-executive Chair
2020DIACEUTICS : Appoints New Nonexecutive Chair
2020Diaceutics PLC Appoints Deborah Davis as Non-Executive Chair, Effective from 4 January ..
2020Diaceutics PLC Announces the Resignation of Julie Goonewardene as Non-Executive Chair, ..
2020DIACEUTICS : and Alva10 partnership to deliver value-based test reimbursement model for US..
2020Diaceutics and Alva10 Partner to Deliver Value-Based Test Reimbursement Model for US Pa..
2020DIACEUTICS : Launches World's First Diagnostic Network for Precision Medicine to Solve Glo..
2020Diaceutics PLC Launches Diagnostic Network for Precision Medicine to Solve Global Cance..
2020DIACEUTICS : Research Predicts NSCLC US Testing Market to Reach $3.6bn by 2025, but Soluti..
2020DIACEUTICS : Partners With Global EQA Providers to Implement Best-in-class Testing Standar..
2020Diaceutics PLC Partners with Global EQA Providers to Implement Best-In-Class Testing St..
2020DIACEUTICS : Unveils Expert Advisory Panel Powering its Industry-Changing Diagnostic Netwo..
2020Diaceutics plc Announces Unaudited Financial Results for the Six Months Ended 30 June 2..
2020Diaceutics PLC announced that it has received £4 million in funding from SVB Silicon Va..
2020Diaceutics PLC Announces Significant New Client Contract Win with a Leading Pharmaceuti..
2020DIACEUTICS : Partners With Targos and HistoCyte Laboratories to Drive Global Diagnostic Te..
2020Diaceutics PLC Partners with Targos and Histocyte Laboratories to Drive Global Diagnost..
2020Diaceutics PLC Announces Trading Update for the Six Months Ended 30 June 2020
2020DIACEUTICS : Collaborates With Industry Advisor Network to Publish Multiple Cancer Insight..
2020DIACEUTICS : announces world's first Diagnostic Network for Precision Medicine following $..
2020Diaceutics PLC Announces DXRX, the Diagnostic Network for Precision Medicine
2020DIACEUTICS : Cancer Testing and Diagnosis Suffers Sharp Downturn, finds Diaceutics
2020Diaceutics PLC Announces Research Results from its COVID-19 Oncology Tracker
202039,124,284 Ordinary Shares of Diaceutics PLC are subject to a Lock-Up Agreement Ending ..
2020Diaceutics plc Reports Earnings Results for the Full Year Ended December 31, 2019
2020DIACEUTICS : FDA to Approve More Precision Than Non-precision Drugs By 2021 – Diaceu..
2020Diaceutics PLC Announces FDA to Approve More Precision Than Non-Precision Drugs by 2021..
2020DIACEUTICS : Belfast investor presentation
2020Diaceutics PLC Provides Earnings Guidance for the Year Ended 31 December 2019
2019DIACEUTICS : Half of Eligible Cancer Patients Missing out on Potentially Life-saving Drugs
2019Diaceutics PLC Announces Unaudited Interim Results for the Six Months Ended 30 June 201..
2019Diaceutics PLC Appoints Derek Hosty as Head of Global Data
2019Diaceutics plc Invests Additional £1 Million in Patient Data to Improve Outcomes
2019Diaceutics PLC has completed an IPO in the amount of £20.75 million.
2019Diaceutics PLC has filed an IPO in the amount of £20.75 million.
2018Diaceutics Launches New Service to Drive Better Access to Diagnostic Testing
2018Diaceutics Raises $5 Million from WhiteRock Capital Partners and Silicon Valley Bank to..
2018Diaceutics Ltd announced that it has received Ä4.3 million in funding from WhiteRock Ca..
2017Diaceutics Real-World Data Shows Fewer Oncology Patients Testing Positive for Targeted ..
2013Diaceutics Appoints Julie Goonewardene Chairwoman of Advisory Board
1  2Volgende
Volgende evenement op DIACEUTICS PLC